Increasing Antitrust Enforcement Under Obama?
On Dec. 16, 2008, the Federal Trade Commission filed a Complaint against Ovation Pharmaceuticals, challenging Ovation's January 2006 acquisition of the drug NeoProfen. The Complaint itself is consistent with traditional antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article